Guangchao Pan

Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy

Ying-Ying Li, Li Ye, Zengrui Tian, 2022, Frontiers in Pharmacology.

Stratification and therapeutic potential of ELL in cytogenetic normal acute myeloid leukemia.

Huiyang Zhou, Mengya Zhong, Qian Lai, 2022, Gene.

Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling

Huiyang Zhou, Mengya Zhong, Zhijuan Lin, 2022, Journal of Cancer Research and Clinical Oncology.

Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway

Mengya Zhong, Chen Xie, Jiewen Huang, 2022, Pharmaceuticals.

Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia.

Huiyang Zhou, Z. Fang, Mengya Zhong, 2022, Cancer letters.

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma

L. Fan, Mengya Zhong, Bing Xu, 2021, Frontiers in Oncology.

Therapeutic Interaction of Apatinib and Chidamide in T-cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis

Mengya Zhong, Bing Xu, Hui Zhou, 2021, Journal of personalized medicine.

Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathway

Mengya Zhong, G. Fu, Jiewen Huang, 2023, Discover Oncology.

High-Throughput Drug Screen for Potential Combinations With Venetoclax Guides the Treatment of Transformed Follicular Lymphoma

Mengya Zhong, Jie Zha, Zhifeng Li, 2023, International journal of toxicology.